ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Align Technology Introduces New Vivera Retainer Doctor Enabled Direct Ship to Patient Feature in Its Doctor Subscription Program

  • The Vivera Retainer Subscription Direct Ship to Patient feature helps doctors support their patients in maintaining their new smiles. Doctors can elect to have retainers shipped directly to their patients reducing the need to store retainers at their practices.
  • The Direct Ship feature creates a more patient friendly workflow for doctors to offer retainers to their patients and reduces the need for patients to make time consuming unnecessary trips to their doctor’s office to pick up their repeat Vivera retainer orders.
  • The Vivera™ Retainer Subscription (VRS) provides a simple and scalable way for doctors to offer ongoing retainers to their patients and preserve their orthodontic treatment results. The Align™ Doctor Subscription Program (DSP) provides doctors with the ability to address patient demand for limited orthodontic treatment for simple “touch up” cases and long-term orthodontic retention.
  • VRS is available to doctors participating in DSP.

Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today introduced a new doctor enabled direct ship to patient feature in its Vivera™ Retainer Subscription (VRS) platform that allows doctors to have subsequent retainers sent directly to their patients in order to meet their ongoing long-term retention needs. The VRS platform is part of Align’s broader Doctor Subscription Program (DSP) introduced to doctors in the United States and Canada in 2021.

“Our new subscription model supports the increasing digitalization of dentistry and orthodontics,” said Simon Beard, Align executive vice president and general manager Americas and EMEA. “As many of us, doctors and their patients have grown to expect the ease and convenience of technology enabled services and solutions. With the introduction of the VRS direct patient ship feature, we are providing doctors with new ways to support their patients, enhance treatment experience, and build their practices.”

With the direct ship to patient feature, doctors can arrange to have subsequent retainers sent to their patients directly, reducing the need for doctors to store the retainers in their office or for patients to make a trip to their doctor’s office simply to pick up their replacement retainers. All shipping costs, logistics, and facilitation of tracking information are managed directly in the Align VRS platform. Doctors can update shipping addresses or preference at their convenience without disrupting patient subscriptions. The doctor enabled Direct Ship feature is only available for repeat retainer orders. All first sets of retainers, whether for an existing or new patient, will be shipped to the doctor’s office so patients can be seen by their doctor as part of their doctor directed treatment plan.

Align introduced the VRS as part of DSP to provide a simple and scalable way for doctors to offer ongoing retainers to their patients and preserve their orthodontic treatment results. It is an end-to-end digital platform that helps doctors manage retainer subscriptions directly with their patients including quotes, patient sign-up, reminders, payment management, renewal, and inventory management. The VRS is fully integrated with the DSP and is available to doctors participating in DSP.

The Align™ DSP addresses practices’ needs for limited orthodontic treatment and retention, digitally giving doctors the opportunity to expand their patient market by tapping into new opportunities with touch up and retention treatments. DSP provides doctors with the flexibility to treat simple orthodontic cases or offer their patients a superior, flexible and convenient retention solution. With DSP, doctors get an allotment of aligners that can be used either for Invisalign Touch Up or Vivera options over the course of 12 months. Doctors pay a predictable payment each month for their limited treatment and retainer needs. DSP is currently available to doctors in the United States and Canada and we are evaluating further expansion of the program.

Align expects to begin a limited market release of the VRS Direct Patient Ship feature with a limited number of current VRS doctors in October 2023.

About Align Technology, Inc.

Align Technology designs and manufactures the Invisalign® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for approximately 247 thousand doctor customers and are key to accessing Align’s 500 million consumer market opportunity worldwide. Over the past 26 years, Align has helped doctors treat over 15.7 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align Digital Platform™, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information. For additional information about the Invisalign System or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.

Invisalign, iTero, exocad, Align, Vivera, and Align Digital Platform are trademarks of Align Technology, Inc.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  213.04
-1.43 (-0.67%)
AAPL  252.30
+4.85 (1.96%)
AMD  233.08
-1.48 (-0.63%)
BAC  51.28
+0.84 (1.67%)
GOOG  253.79
+1.91 (0.76%)
META  716.91
+4.84 (0.68%)
MSFT  513.58
+1.97 (0.39%)
NVDA  183.16
+1.35 (0.74%)
ORCL  291.31
-21.69 (-6.93%)
TSLA  439.31
+10.56 (2.46%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.